Jukka Partanen: How Blood Donation Selection Shapes the Human Genome Landscape
Jukka Partanen, Research Professor At Finnish Red Cross Blood Service, shared on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Human Genetics, adding:
”Are blood donors a random sample from the general population, or a selected one?
Both the criteria set by blood establishments for blood donor and donor’s self-assessment (feeling fit enought to donate blood) results in a repeated selection of individual who regularly donate blood.
This is called the healthy donor effect.
We compared the genome profiles of regular blood donors of the Blood Service Biobank in Finland with other Finnish population cohorts in FinnGen and found that the healthy donor effect indeed is visible at the genome level, too.
Genetic risk variants to many common diseases had lower frequences in regular blood donors – something we must remember when applying blood donor genome data as a reference.”
Title: Genome-wide association study identifies protective genetic factors in active blood donors against multiple diseases
Authors: Jonna Clancy, Jarkko Toivonen, Jouni Lauronen, Jukka Partanen, Mikko Arvas, Jarmo Ritari
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian